Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Greene

Showing results (61-70 of 130) with videos related to

Pageof 13
Sort By:
Environmental Research|October 1, 1979
Cancer mortality among printing plant workersM H Greene, R N Hoover, R L Eck, et al.
American Journal of Obstetrics and Gynecology|June 1, 1984
Prognostic significance of histologic classification and grading of epithelial malignancies of the ovaryG D Malkasian, L J Melton, P C O'Brien, et al.
Cancer Treatment Reports|November 1, 1979
Subsequent cancer in patients with Ewing's sarcomaM H Greene, D L Glaubiger, G D Mead, et al.
Cancer Research|April 1, 1983
Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphomaM H Greene, R C Young, J M Merrill, et al.
Journal of Medical Genetics|November 5, 2002
Family history of breast cancer as a determinant of the risk of developing endometrial cancer: a nationwide cohort studyN Kazerouni, C Schairer, H B Friedman, et al.
Annals of Internal Medicine|February 1, 1981
NIH conference. A multidisciplinary approach to non-hodgkin's lymphomasC W Berard, M H Greene, E S Jaffe, et al.
Cancer Genetics and Cytogenetics|February 1, 1987
Cytogenetics in hereditary malignant melanoma and dysplastic nevus syndrome: is dysplastic nevus syndrome a chromosome instability disorder?N Caporaso, M H Greene, S Tsai, et al.
Archives of Dermatology|February 1, 1981
Topical chemotherapy of dysplastic melanocytic nevi with 5% fluorouracilE E Bondi, W H Clark, D Elder, et al.
Cancer|February 1, 1982
Hairy cell leukemia in three siblings: an apparent HLA-linked diseaseR F Wylin, M H Greene, M Palutke, et al.
Cancer Research|September 15, 1988
Relationship between sensitivity of cells from patients with hereditary cutaneous malignant melanoma to killing and mutations by 4-nitroquinoline 1-oxide and adduct formationK Sato, J N Howell, M H Greene, et al.
Pageof 13

Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
Environmental Research|October 1, 1979
Cancer mortality among printing plant workersM H Greene, R N Hoover, R L Eck, et al.
American Journal of Obstetrics and Gynecology|June 1, 1984
Prognostic significance of histologic classification and grading of epithelial malignancies of the ovaryG D Malkasian, L J Melton, P C O'Brien, et al.
Cancer Treatment Reports|November 1, 1979
Subsequent cancer in patients with Ewing's sarcomaM H Greene, D L Glaubiger, G D Mead, et al.
Cancer Research|April 1, 1983
Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphomaM H Greene, R C Young, J M Merrill, et al.
Journal of Medical Genetics|November 5, 2002
Family history of breast cancer as a determinant of the risk of developing endometrial cancer: a nationwide cohort studyN Kazerouni, C Schairer, H B Friedman, et al.
Annals of Internal Medicine|February 1, 1981
NIH conference. A multidisciplinary approach to non-hodgkin's lymphomasC W Berard, M H Greene, E S Jaffe, et al.
Cancer Genetics and Cytogenetics|February 1, 1987
Cytogenetics in hereditary malignant melanoma and dysplastic nevus syndrome: is dysplastic nevus syndrome a chromosome instability disorder?N Caporaso, M H Greene, S Tsai, et al.
Archives of Dermatology|February 1, 1981
Topical chemotherapy of dysplastic melanocytic nevi with 5% fluorouracilE E Bondi, W H Clark, D Elder, et al.
Cancer|February 1, 1982
Hairy cell leukemia in three siblings: an apparent HLA-linked diseaseR F Wylin, M H Greene, M Palutke, et al.
Cancer Research|September 15, 1988
Relationship between sensitivity of cells from patients with hereditary cutaneous malignant melanoma to killing and mutations by 4-nitroquinoline 1-oxide and adduct formationK Sato, J N Howell, M H Greene, et al.
Pageof 13